The Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a definitive contract valued at $8,305,020 to BCG Federal Corp. to provide consultant support services for the government's COVID-19 response efforts. Specifically, BCG Federal will assist with strategic communications, program analytics, clinical and non-clinical development, as well as chemistry, manufacturing, and controls. Performance will take place in Bethesda, Maryland over a one year base period ending August 31, 2021. The contract has a firm fixed price structure and was awarded under an unrestricted solicitation with no set aside designation. BCG Federal will leverage its expertise supporting the Department of Defense's chemical and biological defense programs to aid the Army's pandemic response initiatives.
Generated 12/29/23, 4:25 PM